Codex DNA, Inc. (DNAY) News & Overview - Discounting Cash Flows
DNAY
Codex DNA, Inc.
DNAY (NASDAQ)

DNAY's Business Model

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Sector & Industry Healthcare / Medical - Devices
Website https://codexdna.com
CEO (Chief Executive Officer) Todd R. Nelson MBA,
Number of Employees
IPO date June 18, 2021

DNAY Latest News

Contact
CountryUS
Address9535 Waples Street
CitySan Diego
StateCA
Phone858 228 4115
Zip Code92121-2993
Other Identifiers
CIK0001850079
ISINUS1920031010
CUSIP192003101
Open1.2
Previous Close1.2
Volume19.95 Thou.
Average Volume79.4 Thou.
Day’s Range1.2 – 1.3093
52 Week Range1.0801-11.02
MA (50)1.394236
MA (200)2.364959
Market Cap38.32 Mil.
Shares Out.29.48 Mil.
Earnings Date
Beta
Last Dividend
EPS
PE

Industry Competitors for DNAY

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us